# Willy Hugo

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/willy-hugo/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,559 |
| Field | Melanoma and MAPK Pathways |
| h-index | 33 |
| i10-index | 44 |
| Last Known Institution | APLA Health |
| OpenAlex ID | https://openalex.org/A5031948300 |
| ORCID iD | https://orcid.org/0000-0002-1426-7190 |
| Works | 198 |

## Researcher papers

- [Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma](https://scholariq.org/papers/neoadjuvant-anti-pd-1-immunotherapy-promotes-a-survival-benefit-with/)

## Researcher topics

- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Computational Drug Discovery Methods](https://scholariq.org/topics/computational-drug-discovery-methods/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)
- [Synthesis and biological activity](https://scholariq.org/topics/synthesis-and-biological-activity/)

## Researcher university

- [APLA Health](https://scholariq.org/institutions/apla-health/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.